Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jun 16, 2025
- Accession no.
- 0001562180-25-004834
- Filed
- Jun 16, 2025
- Trade date
- Jun 12, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.08M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | Common Stock | MOption exerciseAcquired | +11,000 | $135.42 | +$1,489,620 | 47,781 | Direct | |
| Jun 12, 2025 | Common Stock | SSaleDisposed | −506 | $275.98F2 | −$139,645.88 | 47,275 | Direct | |
| Jun 12, 2025 | Common Stock | SSaleDisposed | −1,100 | $276.95F3 | −$304,645 | 46,175 | Direct | |
| Jun 12, 2025 | Common Stock | SSaleDisposed | −1,837 | $278.41F4 | −$511,439.17 | 44,338 | Direct | |
| Jun 12, 2025 | Common Stock | SSaleDisposed | −1,425 | $279.51F5 | −$398,301.75 | 42,913 | Direct | |
| Jun 12, 2025 | Common Stock | SSaleDisposed | −1,375 | $280.70F6 | −$385,962.5 | 41,538 | Direct | |
| Jun 12, 2025 | Common Stock | SSaleDisposed | −4,557 | $281.56F7 | −$1,283,068.92 | 36,981 | Direct | |
| Jun 12, 2025 | Common Stock | SSaleDisposed | −200 | $282.27F8 | −$56,454 | 36,781 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | Common Stock | MOption exerciseDisposed | −11,000 | $0.00 | $0 | 132,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $275.52 to $276.375. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $276.62 to $277.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $278.05 to $279.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $279.06 to $280.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $280.07 USD to $281.04 USD; the price reported above reflects the weighted average sale price.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $281.14 to $282.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $282.25 to $282.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.